American Society of Nephrology Kidney Week 2017

Kidney Week 2017 in New Orleans. The American Society of Nephrology Annual Meeting and Scientific Exposition welcomes more than 13,000 kidney professionals from around the world to this premier kidney meeting.

We provide coverage from the meeting on topics such as:

• Rapid Correction of Severe Hyponatremia
• Tolvaptan Improved Hyponatremia in Patient with Melanoma
• Options Education Impacts Modality Choice for ESRD Patients
• Fluid Overload and AKI and Mortality in Influenza Patients
• Hyponatremia and Impaired Cognitive Function: SPRINT Baseline Data
• Early Mortality in Continuous Renal Replacement Therapy
• Case Report: Patient with Hyponatremia after New Anti-VEGF Therapy
• Use of Statins in Patients with Non-Dialysis Dependent CKD
• Hyponatremia in Newly Diagnosed Dengue Infection

View the meeting program here:

AKI Strong Risk Factor for Mortality in Influenza

New Orleans—Following a pandemic of influenza A(H1N1) in 2009 in Mexico, reports described the presentation of influenza in critically ill patients; there was a high prevalence of acute kidney injury (AKI) and mortality in the reports. In a retrospective, observational study of patients admitted to the intensive care unit (ICU) during the 2016-1027 influenza season, researchers aimed to assess AKI ... Read More »

Following Adjustment for Gout, Recurrent Kidney Stone Formers at Risk for ESRD

New Orleans—In a cohort of 7036 kidney stone formers and 28,136 controls, patients with recurrent kidney stones, but not those with incident kidney stones, were at higher risk of end-stage renal disease and mortality compared with the control group, following adjustment for baseline chronic kidney disease, diabetes mellitus, hypertension, dyslipidemia, obesity, and gout. Patients with asymptomatic kidney stones were also ... Read More »

Vascular Access in the Elderly

New Orleans—Individuals ≥75 years of age represent >57% of patients receiving maintenance dialysis. Arteriovenous fistulas (AVF) have the lowest rates of morbidity and mortality and are the preferred vascular access for hemodialysis; it is unclear, however, that AVF is the optimal access in the elderly. A retrospective study evaluated outcomes in patients who underwent surgery for the creation of a ... Read More »

Central Adiposity in Patients with Type 1 Diabetes and Diabetic Nephropathy

New Orleans—In both the general population and in patients with type 1 diabetes, central adiposity is a key risk factor for cardiorenal risk. A recent study was designed to assess the relationship between central adiposity and renal hemodynamic function in adults with longstanding type 1 diabetes (n=75, duration >50 years) and without diabetic nephropathy (controls; n=75). In the control group, ... Read More »

Kidney Transplant Outcomes in Patients with RPGN

New Orleans—The primary causes of end-stage renal disease (ESRD) due to rapidly progressive glomerulonephritis (RPGN) are antineutrophil cytoplasmic autoantibodies (ANCA) associated vasculitis (AAV) and anti-glomerular basement membrane (anti-PBM). Researchers at the School of Medicine and Public Health at the University of Wisconsin, Madison, reported long-term in renal transplant recipients with EDRS due to RPGN. Outcomes for patients with ESRD due ... Read More »

RP-103 Promotes Growth in Treatment-Naïve Patients ≤6 Years

New Orleans—Nephropathic cystinosis (NC) is a recessive disease in which the lysosomal cysteine exporter is deficient, causing accumulation of intralysomal cysteine; in addition, the biomarker WBC ½ cysteine/mg protein is >1 nmol. Cysteamine bitartrate (Cys-Bi) lowers levels to <1 nmol. Researchers in Brazil conducted a long-term, prospective, controlled, open-label trial of RP-103. Study participants were 17 Cys-Bi naïve patients with ... Read More »

Serum Levels of Uric Acid and Complement C3 Associated with Renal Arteriosclerosis

New Orleans—Previous studies have demonstrated that hyperuricemia (HUA) is related to renal arteriosclerosis in patients with chronic kidney disease (CKD). Researchers in Japan recently examined the significance of concurrent occurrence of HUA and elevated levels of serum complement C3 (C3). The study involved 172 patients with CKD. The mean arteriolar hyalinization grade following HC3/HUA subgrouping and after logarithmic transformation, was ... Read More »

Association Between Blood Pressure and High Uric Acid in CKD Patients

New Orleans—Patients with chronic kidney disease (CKD) with high levels of serum uric acid may be susceptible to hypertensive renal damage. However, according to researchers, there are few data on the effects of high serum uric levels on the relationship between blood pressure levels and proteinuria in CKD. In a recent Japanese study, 109 patients with non-nephrotic CKD who underwent ... Read More »

Early Hospitalization after Dialysis Initiation Increases Risk of All-Cause Mortality

New Orleans—Within the first several months of dialysis initiation, rates of hospitalization and mortality are relatively high, but there are few data available on the association between early hospitalization following dialysis initiation (within 90 days) and clinical outcomes in patients with end-stage renal disease. In a recent study, participants (n=1584) were selected from the Clinical Research Center registry, a prospective ... Read More »

Uric Acid and Renal Pathological Features

New Orleans—Patients with chronic kidney disease (CKD) commonly develop hyperuricemia, which increases the risk of cardiovascular events and accelerates CKD progression. Chinese researchers conducted a study to identify the relationship between baseline uric acid levels and renal pathological features. The study included 1070 patients who underwent renal biopsy at a single center. Of the 1070 patients, 429 were IgA nephropathy ... Read More »